申请人:Bridge Pharma, Inc.
公开号:EP1658847A2
公开(公告)日:2006-05-24
The present invention relates to new aminoindane piperidine compounds, the method of using aminoindane compounds as local anesthetics, said compounds having particularly valuable properties as dermal and topical anesthetics in mammals, including man, as well as compositions containing said compounds.
本发明涉及新的氨基茚满哌啶化合物、使用氨基茚满化合物作为局部麻醉剂的方法(所述化合物作为哺乳动物(包括人类)的皮肤和局部麻醉剂具有特别宝贵的特性)以及含有所述化合物的组合物。